ArticleCancers2022

Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma.

Nadine L Ammann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.